These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 38634048)
1. Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target. Zhao Z; Cui T; Wei F; Zhou Z; Sun Y; Gao C; Xu X; Zhang H Front Oncol; 2024; 14():1367364. PubMed ID: 38634048 [TBL] [Abstract][Full Text] [Related]
2. [Role of Wnt/β-catenin signaling pathway in promoting tumorigenesis of hepatocellular carcinoma]. Xie L; Jiang H; Wu F Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(6):913-7. PubMed ID: 24968856 [TBL] [Abstract][Full Text] [Related]
3. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation. Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529 [TBL] [Abstract][Full Text] [Related]
4. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma. Chen J; Rajasekaran M; Hui KM Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652 [TBL] [Abstract][Full Text] [Related]
5. Matrine improves the hepatic microenvironment and reverses epithelial-mesenchymal transition in hepatocellular carcinoma by inhibiting the Wnt-1/β-catenin signaling pathway. Shi J; Zhang H; Han G; Wang J; Han X; Zhao M; Duan X; Mi L; Li N; Yin X; Li C; Yin F Am J Transl Res; 2023; 15(8):5047-5070. PubMed ID: 37692966 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients. Ashmawy AM; Elgeshy KM; Abdel Salam ET; Ghareeb M; Kobaisi MH; Amin HAA; Sharawy SK; Abdel Wahab AHA Arab J Gastroenterol; 2017 Sep; 18(3):144-150. PubMed ID: 28958640 [TBL] [Abstract][Full Text] [Related]
7. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application. Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517 [TBL] [Abstract][Full Text] [Related]
8. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway. Lou YX; Gu J; Zhu L; Sun SQ; Hao XL; Chen JP; Han F; Wang DD; Jiang X; Liu JY Lab Invest; 2023 Dec; 103(12):100260. PubMed ID: 37839635 [TBL] [Abstract][Full Text] [Related]
9. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation. Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142 [TBL] [Abstract][Full Text] [Related]
10. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway. Lei T; Zhu X; Zhu K; Jia F; Li S Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558 [TBL] [Abstract][Full Text] [Related]
11. Coronin 6 promotes hepatocellular carcinoma progression by enhancing canonical Wnt/beta-catenin signaling pathway. Zhang J; Li P; Li T; Zhou Z; Wu H; Zhang L J Cancer; 2021; 12(24):7465-7476. PubMed ID: 35003366 [TBL] [Abstract][Full Text] [Related]
12. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma. Tsai HW; Cheng SW; Chen CC; Chen IW; Ho CL BMC Cancer; 2023 Oct; 23(1):1025. PubMed ID: 37875822 [TBL] [Abstract][Full Text] [Related]
13. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma. Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955 [TBL] [Abstract][Full Text] [Related]
14. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. Cao F; Yin LX Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797 [TBL] [Abstract][Full Text] [Related]
15. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway. Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway. Xu H; Li B Bioengineered; 2022 May; 13(5):12876-12887. PubMed ID: 35609318 [TBL] [Abstract][Full Text] [Related]
17. Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. Leung RWH; Lee TKW Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358885 [TBL] [Abstract][Full Text] [Related]
18. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment. Vilchez V; Turcios L; Marti F; Gedaly R World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628 [TBL] [Abstract][Full Text] [Related]
19. Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC. Rana MA; Ijaz B; Daud M; Tariq S; Nadeem T; Husnain T Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):373-386. PubMed ID: 30377095 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling. Quan H; Li B; Yang J Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]